Discounted Cash Flow Rating
Buy
Return on Equity Rating
Strong Buy
Debt to Equity Rating
Sell
Price to Earnings Rating
Buy
Analyst Rating
Neutral
Simple Moving Average
Neutral
Exponential Moving Average
Sell
Relative Strength Index
Neutral
Standard Deviation
Buy
Williams %R
Strong Buy
Average Directional Index
Sell
Insider Trading
Strong Buy
Wall Street Data Solutions Rating
Buy
A
TRACON Pharmaceuticals, Inc. Common Stock (TCON)
Biological Products, (no Disgnostic Substances)
TRACON Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and utilizing its cost efficient, contract research organization (CRO) independent product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the United States. The company's drug candidate includes Envafolimab, TRC102, TRC253, and Bispecific Antibodies.
4350 LA JOLLA VILLAGE DRIVE, SUITE 800
San Diego, CA
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
01/30/2015
Market Cap
267,904
Shares Outstanding
31,140,000
Weighted SO
31,144,335
Total Employees
N/A
Upcoming Earnings
08/12/2024
Beta
1.2840
Last Div
0.0000
Range
0.002-14.746
Chg
-0.0066
Avg Vol
131601
Mkt Cap
267904
Exch
NASDAQ
Country
US
Phone
858 550 0780
DCF Diff
-0.1854
DCF
0.2934
Div Yield
0.0000
P/S
0.0837
EV Multiple
0.8224
P/FV
0.0000
Div Yield %
0.0000
P/E
0.0579
PEG
0.0006
Payout
0.0000
Current Ratio
0.6582
Quick Ratio
0.6582
Cash Ratio
0.6339
DSO
0.0000
DIO
0.0000
Op Cycle
0.0000
DPO
87998.1818
CCC
-87998.1818
Gross Margin
0.9966
Op Margin
-2.2828
Pretax Margin
1.6234
Net Margin
1.6234
Eff Tax Rate
-0.4640
ROA
0.7020
ROE
-3.6746
ROCE
2.9326
NI/EBT
1.0000
EBT/EBIT
-0.7112
EBIT/Rev
-2.2828
Debt Ratio
0.0000
D/E
0.0000
LT Debt/Cap
0.0000
Total Debt/Cap
0.0000
Int Coverage
13.1622
CF/Debt
0.0000
Equity Multi
0.0000
Rec Turnover
0.0000
Pay Turnover
0.0041
Inv Turnover
0.0000
FA Turnover
106.6667
Asset Turnover
0.4324
OCF/Share
2.0398
FCF/Share
2.0398
Cash/Share
2.0844
OCF/Sales
1.9175
FCF/OCF
1.0000
CF Coverage
0.0000
ST Coverage
0.0000
CapEx Coverage
0.0000
Div&CapEx Cov
0.0000
P/BV
0.0000
P/B
0.0000
P/S
0.0837
P/E
0.0579
P/FCF
0.0437
P/OCF
0.0490
P/CF
0.0490
PEG
0.0006
P/S
0.0837
EV Multiple
0.8224
P/FV
0.0000
DPS
0.0000
Latest Headlines (EST)
No Headlines Found
Revenue Product Segmentation
Year | Purchases | Sales | Total Bought | Total Sold |
---|
Transaction Date | Name | Type Of Owner | Price | Securities Owned | Securities Transacted | Security Name | Transaction Type |
---|
Less Than 3 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0%)
3 - 6 Months
743.10K Shares Bought (100.00 %)
0.00 Shares Sold (0.00%)
6 - 9 Months
3.50K Shares Bought (99.97 %)
0.00 Shares Sold (0.03%)
9 - 12 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0 %)
Investor Name | Investment Discretion | Type of Security | Shares Owned | Avg Price Paid | Market Value | Change In Market Value | Change In Market Value (%) | Ownership | Weight |
---|
Date | Investors Holding | Closed Positions | Increased Positions | Reduced Positions | New Positions | Total Invested | Put/Call Ratio | Total Calls | Total Puts |
---|
Owner | Shares Owned |
---|
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 3.05M | ▼ 100.00K |
Cost Of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 4.00K | ▼ 3.00K | ▲ 4.00K |
Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -4.00K | ▲ 3.04M | ▼ 96.00K |
Gross Profit Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 1.00 | ▼ 0.96 |
Research And Development Expenses | 5.93M | ▼ 1.91M | ▲ 2.20M | ▲ 3.06M | ▲ 3.88M | ▼ 1.49M | ▲ 1.87M |
General And Administrative Expenses | 1.80M | ▲ 1.90M | ▲ 1.98M | ▲ 4.60M | ▼ 1.96M | ▼ 1.14M | ▲ 1.43M |
Selling And Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling General And Administrative Expenses | 1.80M | ▲ 1.90M | ▲ 1.98M | ▲ 4.60M | ▼ 1.96M | ▼ 1.14M | ▲ 1.43M |
Other Expenses | 2.00K | ▼ -124.00K | ▲ -1.00K | ▼ -49.00K | ▼ -1.17M | ▲ -5.00K | ▼ -9.00K |
Operating Expenses | 7.73M | ▼ 3.81M | ▲ 4.18M | ▲ 7.66M | ▼ 5.83M | ▼ 2.64M | ▲ 3.31M |
Cost And Expenses | 7.73M | ▼ 3.81M | ▲ 4.18M | ▲ 7.66M | ▼ 5.83M | ▼ 2.64M | ▲ 3.31M |
Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 918.00K | ▼ -7.34M | ▲ 0.00 |
Interest Expense | 27.00K | ▲ 133.00K | 133.00K | ▼ 49.00K | ▲ 918.00K | ▼ -37.00K | ▲ 53.00K |
Depreciation And Amortization | 7.00K | ▼ 1.00K | ▼ -6.00K | ▼ -28.00K | ▲ 11.00K | ▼ 3.00K | ▲ 4.00K |
Ebitda | -7.73M | ▲ -3.81M | ▼ -4.18M | ▼ -7.66M | ▲ -5.83M | ▲ 410.00K | ▼ -3.21M |
Ebitda Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 0.13 | ▼ -32.08 |
Operating Income | -7.73M | ▲ -3.81M | ▼ -4.18M | ▼ -7.66M | ▲ -5.83M | ▲ 407.00K | ▼ -3.21M |
Operating Income Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 0.13 | ▼ -32.12 |
Total Other Income Expenses Net | -25.00K | ▼ -124.00K | ▲ -1.00K | ▼ -49.00K | ▼ -1.17M | ▲ 32.00K | ▲ 44.00K |
Income Before Tax | -7.76M | ▲ -3.94M | ▼ -4.31M | ▼ -7.71M | ▲ -7.00M | ▲ 439.00K | ▼ -3.17M |
Income Before Tax Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 0.14 | ▼ -31.68 |
Income Tax Expense | -7.00K | ▲ -1.00K | ▲ 138.00K | ▼ 28.00K | ▲ 236.00K | ▼ -2.36M | ▲ 0.00 |
Net Income | -7.76M | ▲ -3.94M | ▼ -4.31M | ▼ -7.71M | ▲ -7.23M | ▲ 439.00K | ▼ -3.17M |
Net Income Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 0.14 | ▼ -31.68 |
Eps | -2.59 | ▲ -1.25 | ▲ -0.28 | ▼ -0.40 | ▲ -0.32 | ▲ 0.01 | ▼ -1.33 |
Eps Diluted | -2.59 | ▲ -1.25 | ▲ -0.28 | ▼ -0.40 | ▲ -0.32 | ▲ 0.01 | ▼ -1.33 |
Weighted Average Shs Out | 2.99M | ▲ 3.16M | ▲ 15.48M | ▲ 19.44M | ▲ 22.29M | ▲ 40.20M | ▼ 2.39M |
Weighted Average Shs Out Dil | 2.99M | ▲ 3.16M | ▲ 15.48M | ▲ 19.44M | ▲ 22.29M | ▲ 40.20M | ▼ 2.39M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Cash And Cash Equivalents | 25.14M | ▼ 16.41M | ▲ 32.13M | ▼ 24.07M | ▼ 17.43M | ▼ 8.56M | ▼ 7.89M |
Short Term Investments | 13.97M | ▼ 0.00 | ▲ 4.00M | ▼ 0.00 | 0.00 | 0.00 | 0.00 |
Cash And Short Term Investments | 39.10M | ▼ 16.41M | ▲ 36.13M | ▼ 24.07M | ▼ 17.43M | ▼ 8.56M | ▼ 7.89M |
Net Receivables | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Current Assets | 1.50M | ▼ 848.00K | ▼ 784.00K | ▲ 864.00K | ▼ 795.00K | ▼ 526.00K | ▼ 511.00K |
Total Current Assets | 40.60M | ▼ 17.26M | ▲ 36.91M | ▼ 24.94M | ▼ 18.23M | ▼ 9.09M | ▼ 8.40M |
Property Plant Equipment Net | 45.00K | ▼ 23.00K | ▼ 16.00K | ▲ 50.00K | ▲ 51.00K | ▲ 942.00K | ▼ 33.00K |
Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Goodwill And Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Long Term Investments | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 67.00K | ▲ 73.00K | 73.00K |
Tax Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Non Current Assets | 0.00 | ▲ 838.00K | ▼ 508.00K | ▲ 1.57M | ▼ 1.12M | ▼ 0.00 | ▲ 847.00K |
Total Non Current Assets | 45.00K | ▲ 861.00K | ▼ 524.00K | ▲ 1.62M | ▼ 1.24M | ▼ 1.02M | ▼ 953.00K |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Assets | 40.65M | ▼ 18.12M | ▲ 37.44M | ▼ 26.56M | ▼ 19.47M | ▼ 10.11M | ▼ 9.36M |
Account Payables | 0.00 | 0.00 | ▲ 1.73M | ▲ 4.94M | ▼ 3.92M | ▲ 9.76M | ▼ 2.68M |
Short Term Debt | 1.08M | ▲ 2.60M | ▲ 3.14M | ▼ 1.39M | ▲ 9.81M | ▼ 236.00K | ▼ 0.00 |
Tax Payables | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Revenue | 0.00 | 0.00 | ▲ 4.51M | ▼ 147.00K | ▼ 0.00 | ▼ -236.00K | ▲ 0.00 |
Other Current Liabilities | 12.41M | ▼ 9.23M | ▼ 1.17M | ▲ 7.20M | ▲ 8.64M | ▼ 427.00K | ▲ 7.77M |
Total Current Liabilities | 13.50M | ▼ 11.83M | ▼ 10.54M | ▲ 13.68M | ▲ 22.37M | ▼ 10.18M | ▲ 10.45M |
Long Term Debt | 5.34M | ▼ 2.74M | ▼ 1.39M | ▼ 0.00 | ▲ 969.00K | ▼ 732.00K | ▼ 0.00 |
Deferred Revenue Non Current | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax Liabilities Non Current | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Non Current Liabilities | 368.00K | ▲ 850.00K | ▼ 432.00K | ▲ 1.17M | ▲ 3.28M | ▼ -1.00 | ▲ 667.00K |
Total Non Current Liabilities | 5.71M | ▼ 3.59M | ▼ 1.82M | ▼ 1.17M | ▲ 4.25M | ▼ 732.00K | ▼ 667.00K |
Other Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 1.00 | ▼ 0.00 |
Capital Lease Obligations | 0.00 | 0.00 | ▲ 418.00K | ▼ 147.00K | ▲ 198.00K | ▲ 732.00K | ▼ 0.00 |
Total Liabilities | 19.21M | ▼ 15.42M | ▼ 12.37M | ▲ 14.84M | ▲ 26.62M | ▼ 10.91M | ▲ 11.12M |
Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 1.00 |
Common Stock | 30.00K | ▼ 4.00K | ▲ 15.00K | ▲ 19.00K | ▲ 23.00K | ▲ 44.00K | ▼ 3.00K |
Retained Earnings | -139.66M | ▼ -162.33M | ▼ -179.11M | ▼ -207.78M | ▼ -236.91M | ▼ -240.50M | ▼ -243.67M |
Accumulated Other Comprehensive Income Loss | -128.00K | ▼ -150.00K | ▲ 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Total Stockholders Equity | 161.20M | ▲ 165.18M | ▲ 204.17M | ▲ 219.47M | ▲ 229.74M | ▲ 239.65M | ▲ 241.90M |
Total Stockholders Equity | 21.44M | ▼ 2.70M | ▲ 25.07M | ▼ 11.71M | ▼ -7.15M | ▲ -809.00K | ▼ -1.76M |
Total Equity | 21.44M | ▼ 2.70M | ▲ 25.07M | ▼ 11.71M | ▼ -7.15M | ▲ -809.00K | ▼ -1.76M |
Total Liabilities And Stockholders Equity | 40.65M | ▼ 18.12M | ▲ 37.44M | ▼ 26.56M | ▼ 19.47M | ▼ 10.11M | ▼ 9.36M |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Liabilities And Total Equity | 40.65M | ▼ 18.12M | ▲ 37.44M | ▼ 26.56M | ▼ 19.47M | ▼ 10.11M | ▼ 9.36M |
Total Investments | 13.97M | ▼ 0.00 | ▲ 4.00M | ▼ 0.00 | ▲ 67.00K | ▲ 73.00K | 73.00K |
Total Debt | 6.43M | ▼ 5.34M | ▼ 4.53M | ▼ 1.39M | ▲ 9.81M | ▼ 732.00K | ▼ 0.00 |
Net Debt | -18.71M | ▲ -11.07M | ▼ -27.60M | ▲ -22.68M | ▲ -7.63M | ▼ -7.83M | ▼ -7.89M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Net Income | -7.76M | ▲ -3.94M | ▼ -4.31M | ▼ -7.71M | ▲ -7.00M | ▲ 439.00K | ▼ -3.17M |
Depreciation And Amortization | 7.00K | ▼ 1.00K | ▼ -6.00K | ▼ -28.00K | ▲ 11.00K | ▼ 3.00K | ▲ 4.00K |
Deferred Income Tax | -44.00K | ▲ 0.00 | ▼ -1.00K | ▲ 0.00 | 0.00 | ▲ 617.00K | ▼ 0.00 |
Stock Based Compensation | 623.00K | ▼ 297.00K | ▼ 264.00K | ▲ 514.00K | ▼ 477.00K | ▲ 490.00K | ▼ 383.00K |
Change In Working Capital | -1.04M | ▲ -675.00K | ▲ 395.00K | ▲ 2.10M | ▼ 864.00K | ▼ -1.46M | ▲ 234.00K |
Accounts Receivables | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Accounts Payables | 2.56M | ▼ -3.42M | ▲ -1.88M | ▲ 4.68M | ▼ -271.00K | ▼ -856.00K | ▲ 232.00K |
Other Working Capital | -3.61M | ▲ 2.75M | ▼ 2.27M | ▼ -2.58M | ▲ 1.14M | ▼ -602.00K | ▲ 2.00K |
Other Non Cash Items | 86.00K | ▼ 70.00K | ▼ 33.00K | ▼ 12.00K | ▲ 992.00K | ▼ -613.00K | ▲ 163.00K |
Net Cash Provided By Operating Activities | -8.13M | ▲ -4.24M | ▲ -3.63M | ▼ -5.11M | ▲ -4.65M | ▲ -522.00K | ▼ -2.54M |
Investments In Property Plant And Equipment | 0.00 | 0.00 | ▼ -5.00K | ▼ -9.00K | ▲ -4.00K | ▲ 0.00 | 0.00 |
Acquisitions Net | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Purchases Of Investments | -13.95M | ▲ 0.00 | ▼ -4.00M | ▲ 0.00 | 0.00 | 0.00 | 0.00 |
Sales Maturities Of Investments | 19.00M | ▼ 0.00 | 0.00 | ▲ 4.00M | ▼ 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | ▼ -4.00M | ▲ 0.00 | 0.00 | 0.00 |
Net Cash Used For Investing Activities | 5.05M | ▼ 0.00 | ▼ -4.00M | ▲ -9.00K | ▲ -4.00K | ▲ 0.00 | 0.00 |
Debt Repayment | -8.32M | ▲ -700.00K | ▲ -467.00K | ▼ -700.00K | ▼ -1.68M | ▼ -20.50M | ▲ 0.00 |
Common Stock Issued | -2.22M | ▲ 2.29M | ▲ 13.77M | ▼ -6.00K | ▲ 1.47M | ▼ 1.32M | ▲ 1.87M |
Common Stock Repurchased | 0.00 | ▲ 450.00K | ▼ 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividends Paid | 0.00 | ▼ -24.00K | ▲ 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 10.55M | ▼ -418.00K | ▲ 3.00K | ▼ 0.00 | ▲ 5.16M | ▲ 20.50M | ▼ 1.87M |
Net Cash Used Provided By Financing Activities | 15.00K | ▲ 1.60M | ▲ 13.31M | ▼ -706.00K | ▲ 4.95M | ▼ 1.32M | ▲ 1.87M |
Effect Of Forex Changes On Cash | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash | -3.06M | ▲ -2.64M | ▲ 5.68M | ▼ -5.83M | ▲ 288.00K | ▲ 801.00K | ▼ -673.00K |
Cash At End Of Period | 25.14M | ▼ 16.41M | ▲ 32.13M | ▼ 24.07M | ▼ 17.50M | ▼ 8.56M | ▼ 7.89M |
Cash At Beginning Of Period | 28.19M | ▼ 19.05M | ▲ 26.45M | ▲ 29.90M | ▼ 17.21M | ▼ 7.76M | ▲ 8.56M |
Operating Cash Flow | -8.13M | ▲ -4.24M | ▲ -3.63M | ▼ -5.11M | ▲ -4.65M | ▲ -522.00K | ▼ -2.54M |
Capital Expenditure | 0.00 | 0.00 | ▼ -5.00K | ▼ -9.00K | ▲ -4.00K | ▲ 0.00 | 0.00 |
Free Cash Flow | -8.13M | ▲ -4.24M | ▲ -3.63M | ▼ -5.12M | ▲ -4.66M | ▲ -522.00K | ▼ -2.54M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
Generating AI Summary...
(This could take up to 5 minutes)